Nice idea from Erlangen: B cell then T cell suppression for ACPA+ RA. A tolergenic reset of sorts. Sounds interesting… small study, but sadly no difference over ritux only. Does seem broadly safe though - maybe will be a strategy for another disease! #EULAR2024 OP0069 @RheumNow https://t.co/mXUS4kpRCK